Location History:
- Parma, IT (2016 - 2020)
- Lesignano de' Bagni, IT (2020)
- Heidelberg, DE (2023)
Company Filing History:
3 out of 155 
1 out of 1 Years Active: 2016-2023
Title: Angelo Bolchi: Innovator in Immunology
Introduction
Angelo Bolchi is a notable inventor based in Parma, Italy, recognized for his contributions to the field of immunology. He holds a total of 4 patents, showcasing his innovative approach to medical science and vaccine development.
Latest Patents
One of Bolchi's latest patents is for a cutaneous papilloma virus vaccine. This invention relates to an immunogenic polypeptide that comprises a multitude of papillomavirus (PV) L2 N-terminal peptides corresponding to amino acids 20 to 50 of the L2 polypeptide of HPV16. The vaccine is designed for use in medicine and vaccination against cutaneous HPV infection and/or mucosal HPV infection. Additionally, it includes a polynucleotide encoding the immunogenic polypeptide and methods for producing related antibodies. Another significant patent involves VHH constructs for diverting an immune response. This invention features a novel VHH construct that can be bound by a complete antibody without impairing its antigen-binding properties. It also includes an antibody construct comprising this VHH construct and its applications in immunodiagnostics and therapeutics.
Career Highlights
Throughout his career, Bolchi has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum and Preclinics Gesellschaft für Präklinische Forschung mbH. His work in these institutions has significantly contributed to advancements in cancer research and vaccine development.
Collaborations
Bolchi has collaborated with notable professionals in his field, including Simone Ottonello and Martin Müller. These partnerships have fostered innovation and enhanced the impact of his research.
Conclusion
Angelo Bolchi's work exemplifies the spirit of innovation in the medical field, particularly in vaccine development and immunology. His patents reflect a commitment to advancing healthcare solutions and addressing critical health challenges.